HYDRONEB 500 CAPSULES

Product Description

HYDRONEB 500 CAPSULES contain Hydroxyurea IP 500mg, a critical medication widely prescribed for managing sickle cell anemia, chronic myeloid leukemia (CML), and other myeloproliferative disorders. Known for its ability to reduce painful crises and improve blood flow, Hydroxyurea plays a vital role in enhancing patient quality of life.

Manufactured in WHO-GMP certified facilities, HYDRONEB 500 ensures superior purity, consistent dosage, and reliable therapeutic outcomesmaking it an essential product for hospital pharmacies, medical distributors, and bulk pharmaceutical buyers.

Key Benefits:

• Effective in reducing the frequency of sickle cell crises

• Plays a pivotal role in cancer therapy for certain blood disorders

• Manufactured with stringent quality control for maximum efficacy

• Supports long-term treatment plans with high patient compliance

Applications:

• Treatment of sickle cell disease to prevent vaso-occlusive episodes

• Used in hematology for managing chronic myeloid leukemia and other blood cancers

• Integral in oncology and hematology pharmacy inventories

Ideal For:

• Pharmaceutical distributors and wholesalers catering to hematology and oncology segments

• Retail chains and hospital pharmacies requiring bulk stock

• Government and private sector bulk procurement